The FDA approves zuranolone, a new option for the treatment of PPD, a rapidly acting antidepressant with a good safety profile.
The post New Oral Drug Zuranolone (Zurzuvae) for Postpartum Depression is Now Available appeared first on MGH Center for Women’s Mental Health.